Timothy Ko came to the psychedelic space as a result of his deeply personal connections with depression, anxiety, and addiction. As the CEO of Entheon Biomedical, an organization working on a legal IV DMT protocol, Timothy is dedicated to providing an effective and scalable therapy that will serve as a vital resource for those afflicted with a substance-use disorder, and who are wanting to reclaim their lives.

Find out more about Entheon Biomedical here: (CSE: ENBI | OTCQB: ENTBF) https://entheonbiomedical.com/